NewGenIvf Group Ltd. has announced a reverse stock split of its shares at a ratio of one-for-five, reducing the number of its outstanding Class A Ordinary Shares from approximately 4.84 million to about 969,000. The move aims to help the company maintain compliance with the Nasdaq's minimum bid price requirement. The reverse split is expected to take effect on or around December 3, 2025, with the shares beginning to trade on a post-split basis on that date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewGenIvf Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-108193), on November 10, 2025, and is solely responsible for the information contained therein.